Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

New syndicated reports now available

Living with CD, PsO, IPF & PF-ILD 2023

Inizio

Hyper-personalisation – The immediate future of pharma is personalised.

What does hyper-personalisation in Pharma look like?

Mednet

Train your brain for success

In this episode of Impetus Digital‘s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Max Newlon, President of Brain Co. They discuss everything from...

Impetus Digital

- PMLiVE

Sobi to acquire CTI BioPharma for approximately $1.7bn

The deal marks a notable expansion to the Swedish drugmaker's rare haematology pipeline

- PMLiVE

Novavax announces positive phase 2 results for COVID-19/influenza vaccine candidates

A combination COVID-19/influenza vaccine is included in the mid-stage study

- PMLiVE

Sandoz and Just-Evotec Biologics announce multi-year biosimilar partnership

The Novartis unit will aim to expand its current pipeline of biosimilars to about 24 candidates

Virtual Patient Steering Committee: A Customer Story

A French pharmaceutical team contacted Impetus Digital to help them establish a Virtual Steering Committee for patients with HIV/AIDS. They wanted to find a way to directly involve patients in...

Impetus Digital

Article: Could combating stigma increase the uptake of PrEP and finally end the HIV epidemic?

In this article we explore what more could be done by the pharmaceutical industry to help prevent the spread of HIV infection worldwide.

Inizio

- PMLiVE

Webcast: China Update 2023: How will recent developments impact your brand’s success?

Register for this live webinar in which emerging market experts provide an update regarding the implications of changing demographics and the healthcare landscape.

Inizio

- PMLiVE

AstraZeneca’s heart failure treatment approved for expanded use in US

Chronic heart failure is the leading cause of hospitalisation for those over the age of 65

- PMLiVE

GSK’s RSV vaccine approved by FDA for older adults

Arexvy is the first RSV vaccine for this age group to be approved anywhere in the world

- PMLiVE

Positive results for Sanofi/Regeneron’s Dupixent published in Nature Medicine

The biologic was shown to significantly improve uncontrolled prurigo nodularis symptoms

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links